81 FR 58950 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 166 (August 26, 2016)

Page Range		58950-58951
FR Document		2016-20440

Federal Register, Volume 81 Issue 166 (Friday, August 26, 2016)

[Federal Register Volume 81, Number 166 (Friday, August 26, 2016)]
[Notices]
[Pages 58950-58951]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20440]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the

[[Page 58951]]

provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Investigator Initiated 
Program Project Applications (P01).
    Date: September 27, 2016.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Ann Marie M. Cruz, Ph.D., Scientific Review 
Officer, Program Management & Operations Branch, DEA/SRP RM 3E71, 
National Institutes of Health, NIAID, 5601 Fishers Lane, Rockville, 
MD 20852, 301-761-3100, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 22, 2016.
Natasha M. Copeland,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-20440 Filed 8-25-16; 8:45 am]
 BILLING CODE 4140-01-P

58950 Federal Register / Vol. 81, No. 166 / Friday, August 26, 2016 / Notices

Potential Commercial Applications: attendance limited to space available. DEPARTMENT OF HEALTH AND
• Diagnostic for colorectal cancer. Individuals who plan to attend and HUMAN SERVICES
need special assistance, such as sign
Value Proposition: language interpretation or other National Institutes of Health
• Assay has high specificity. reasonable accommodations, should
• Fresh and frozen samples can be National Heart, Lung, and Blood
notify the Contact Person listed below
utilized by this assay. Institute; Notice of Closed Meeting
in advance of the meeting.
Development Stage: The meeting will be closed to the Pursuant to section 10(d) of the
public in accordance with the Federal Advisory Committee Act, as
Pre-clinical (in vivo validation).
provisions set forth in sections amended (5 U.S.C. App.), notice is
Inventor(s):
James J. Goedert (NCI) and Rashmi 552b(c)(4) and 552b(c)(6), title 5 U.S.C., hereby given of the following meeting.
Sinha (NCI). as amended. The grant applications The meeting will be closed to the
public in accordance with the
Intellectual Property: and/or contract proposals and the
provisions set forth in sections
discussions could disclose confidential
HHS Reference No. E–198–2014/0– 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
trade secrets or commercial property as amended. The grant applications and
PCT–02. such as patentable material, and
International PCT Application No. the discussions could disclose
personal information concerning confidential trade secrets or commercial
PCT/US2015/038299 (HHS Reference
No. E–198–2014/0–PCT–02) filed June individuals associated with the grant property such as patentable material,
29, 2015 entitled, ‘‘Detection of applications and/or contract proposals, and personal information concerning
Colorectal Cancer with Two Novel the disclosure of which would individuals associated with the grant
Heme-Related Molecules in Human constitute a clearly unwarranted applications, the disclosure of which
Feces.’’ invasion of personal privacy. would constitute a clearly unwarranted
Name of Committee: National Advisory invasion of personal privacy.
Publications:
Council for Biomedical Imaging and Name of Committee: National Heart, Lung,
1. J.J. Goedert et al. Fecal Metabolomics: Bioengineering. and Blood Institute Special Emphasis Panel;
Assay Performance and Association Date: September 15, 2016. Zika R21 Rapid Review.
with Colorectal Cancer. Open: 8:30 a.m. to 12:00 p.m. Date: September 21, 2016.
Carcinogenesis. 2014 Sep;35(9):2089– Agenda: Report from the Institute Director, Time: 1:00 p.m. to 2:00 p.m.
96. [PMID: 25037050]. other Institute Staff and scientific Agenda: To review and evaluate grant
presentation. applications.
Collaboration Opportunity Place: National Institutes of Health, 6701
Place: The William F. Bolger Center,
The NCI seeks licensing or co- Rockledge Drive, Room 7189, Bethesda, MD
Franklin Building, Classroom 15/16, 9600 20892, (Telephone Conference Call).
development collaborations the would Newbridge Drive, Potomac, MD 20854. Contact Person: Stephanie L Constant,
enable eventual commercialization of Closed: 1:30 p.m. to 3:30 p.m. Ph.D., Scientific Review Officer, Office of
the diagnostic technology. Agenda: To review and evaluate grant Scientific Review/DERA, National Heart,
Contact Information applications and/or proposals. Lung, and Blood Institute, 6701 Rockledge
Place: The William F. Bolger Center, Drive, Room 7189, Bethesda, MD 20892, 301–
Requests for copies of the patent Franklin Building, Classroom 15/16, 9600 443–8784, constantsl@nhlbi.nih.gov.
application or inquiries about licensing, Newbridge Drive, Potomac, MD 20854. (Catalogue of Federal Domestic Assistance
research collaborations, and co- Contact Person: David T. George, Ph.D., Program Nos. 93.233, National Center for
development opportunities should be Acting Associate Director, Office of Research Sleep Disorders Research; 93.837, Heart and
sent to John D. Hewes, Ph.D., email: Administration, National Institute of Vascular Diseases Research; 93.838, Lung
john.hewes@nih.gov. Biomedical Imaging, and Bioengineering, Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
Dated: August 17, 2016. 6707 Democracy Boulevard, Room 920,
of Health, HHS)
John D. Hewes, Bethesda, MD 20892.
Technology Transfer Specialist, Technology Any interested person may file written Dated: August 22, 2016.
Transfer Center, National Cancer Institute. comments with the committee by forwarding Michelle Trout,
[FR Doc. 2016–20444 Filed 8–25–16; 8:45 am] the statement to the Contact Person listed on Program Analyst, Office of Federal Advisory
BILLING CODE 4140–01–P
this notice. The statement should include the Committee Policy.
name, address, telephone number and when [FR Doc. 2016–20438 Filed 8–25–16; 8:45 am]
applicable, the business or professional BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND affiliation of the interested person.
HUMAN SERVICES Information is also available on the
Institute’s/Center’s home page: http:// DEPARTMENT OF HEALTH AND
National Institutes of Health www.nibib1.nih.gov/about/NACBIB/ HUMAN SERVICES
NACBIB.htm, where an agenda and any
National Institute of Biomedical additional information for the meeting will National Institutes of Health
Imaging and Bioengineering; Notice of be posted when available.
Meeting National Institute of Allergy and
Dated: August 22, 2016. Infectious Diseases; Notice of Closed
Pursuant to section 10(d) of the
mstockstill on DSK3G9T082PROD with NOTICES

David Clary, Meeting
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is Program Analyst, Office of Federal Advisory Pursuant to section 10(d) of the
hereby given of a meeting of the Committee Policy. Federal Advisory Committee Act, as
National Advisory Council for [FR Doc. 2016–20437 Filed 8–25–16; 8:45 am] amended (5 U.S.C. App.), notice is
Biomedical Imaging and Bioengineering. BILLING CODE 4140–01–P hereby given of the following meeting.
The meeting will be open to the The meeting will be closed to the
public as indicated below, with public in accordance with the

VerDate Sep<11>2014 21:17 Aug 25, 2016 Jkt 238001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\26AUN1.SGM 26AUN1

Federal Register / Vol. 81, No. 166 / Friday, August 26, 2016 / Notices 58951

provisions set forth in sections Date: September 28, 2016. Name of Committee: National Institute of
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Time: 10:00 a.m. to 4:00 p.m. Biomedical Imaging and Bioengineering
as amended. The grant applications and Agenda: To review and evaluate contract Special Emphasis Panel; Health Disparity
proposals. SBIR Review (2017/01).
the discussions could disclose
Place: National Institutes of Health, Room Date: October 26, 2016.
confidential trade secrets or commercial 2H200AB, 5601 Fishers Lane, Rockville, MD Time: 10:00 a.m. to 6:00 p.m.
property such as patentable material, 20892 (Telephone Conference Call). Agenda: To review and evaluate grant
and personal information concerning Contact Person: Vasundhara Varthakavi, applications.
individuals associated with the grant DVM, Ph.D., Scientific Review Officer Place: National Institutes of Health, Two
applications, the disclosure of which Scientific Review Program, Division of Democracy Plaza, Suite 920, 6707 Democracy
would constitute a clearly unwarranted Extramural Activities, Room 3E70, National Boulevard, Bethesda, MD 20892 (Virtual
invasion of personal privacy. Institutes of Health, NIAID, 5601 Fishers Meeting).
Lane, MSC 9823, Bethesda, MD 20892–9823, Contact Person: Dennis Hlasta, Ph.D.,
Name of Committee: National Institute of (240) 669–5020, varthakaviv@niaid.nih.gov. Scientific Review Officer, National Institute
Allergy and Infectious Diseases Special of Biomedical Imaging and Bioengineering,
(Catalogue of Federal Domestic Assistance
Emphasis Panel; NIAID Investigator Initiated National Institutes of Health, 6707
Program Project Applications (P01). Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856, Democracy Blvd., Bethesda, MD 20892, (301)
Date: September 27, 2016. 451–4794, dennis.hlasta@nih.gov.
Time: 1:00 p.m. to 5:00 p.m. Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS) Name of Committee: National Institute of
Agenda: To review and evaluate grant
Biomedical Imaging and Bioengineering
applications. Dated: August 22, 2016.
Place: National Institutes of Health 5601 Special Emphasis Panel; T32–R25 Training
Natasha M. Copeland, Review Meeting (2017/01).
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call). Program Analyst, Office of Federal Advisory Date: November 7, 2016.
Contact Person: Ann Marie M. Cruz, Ph.D., Committee Policy. Time: 9:30 a.m. to 7:00 p.m.
Scientific Review Officer, Program [FR Doc. 2016–20441 Filed 8–25–16; 8:45 am] Agenda: To review and evaluate grant
Management & Operations Branch, DEA/SRP applications.
BILLING CODE 4140–01–P
RM 3E71, National Institutes of Health, Place: National Institutes of Health, Two
NIAID, 5601 Fishers Lane, Rockville, MD Democracy Plaza, Suite 920, 6707 Democracy
20852, 301–761–3100, AnnMarie.Cruz@ Boulevard, Bethesda, MD 20892 (Telephone
DEPARTMENT OF HEALTH AND Conference Call).
niaid.nih.gov.
HUMAN SERVICES Contact Person: John K. Hayes, Ph.D.,
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology, Scientific Review Officer, 6707 Democracy
National Institutes of Health Blvd., Suite 959, Democracy Two, Bethesda,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases MD 20892, (301) 451–3398, hayesj@
National Institute of Biomedical mail.nih.gov.
Research, National Institutes of Health, HHS)
Imaging and Bioengineering; Notice of
Dated: August 22, 2016. Closed Meetings Dated: August 22, 2016.
Natasha M. Copeland, David Clary,
Pursuant to section 10(d) of the Program Analyst, Office of Federal Advisory
Program Analyst, Office of Federal Advisory
Committee Policy. Federal Advisory Committee Act, as Committee Policy.
amended (5 U.S.C. App.), notice is
[FR Doc. 2016–20440 Filed 8–25–16; 8:45 am] [FR Doc. 2016–20447 Filed 8–25–16; 8:45 am]
hereby given of the following meetings.
BILLING CODE 4140–01–P BILLING CODE 4140–01–P
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
HUMAN SERVICES HUMAN SERVICES
as amended. The grant applications and
National Institutes of Health the discussions could disclose National Institutes of Health
confidential trade secrets or commercial
National Institute of Allergy and property such as patentable material, Center for Scientific Review; Notice of
Infectious Diseases; Notice of Closed and personal information concerning Closed Meetings
Meeting individuals associated with the grant
applications, the disclosure of which Pursuant to section 10(d) of the
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
would constitute a clearly unwarranted
Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is
invasion of personal privacy.
amended (5 U.S.C. App.), notice is hereby given of the following meetings.
hereby given of the following meeting. Name of Committee: National Institute of The meetings will be closed to the
The meeting will be closed to the Biomedical Imaging and Bioengineering public in accordance with the
public in accordance with the Special Emphasis Panel; MSM Program provisions set forth in sections
Review (2017/01).
provisions set forth in sections Date: October 24, 2016.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Time: 10:00 a.m. to 6:00 p.m. as amended. The grant applications and
as amended. The contract proposals and Agenda: To review and evaluate grant the discussions could disclose
the discussions could disclose applications. confidential trade secrets or commercial
confidential trade secrets or commercial Place: National Institutes of Health, Two property such as patentable material,
property such as patentable material, Democracy Plaza, Suite 920, 6707 Democracy and personal information concerning
and personal information concerning Boulevard, Bethesda, MD 20892 (Virtual individuals associated with the grant
mstockstill on DSK3G9T082PROD with NOTICES

individuals associated with the contract Meeting). applications, the disclosure of which
proposals, the disclosure of which Contact Person: Manana Sukhareva, Ph.D., would constitute a clearly unwarranted
Scientific Review Officer, National Institute
would constitute a clearly unwarranted of Biomedical Imaging and Bioengineering,
invasion of personal privacy.
invasion of personal privacy. National Institutes of Health, 6707 Name of Committee: Center for Scientific
Name of Committee: National Institute of Democracy Boulevard, Suite 959, Bethesda, Review Special Emphasis Panel, Molecular
Allergy and Infectious Diseases Special MD 20892, (301) 451–4773, sukharem@ Mechanisms of Membrane Transport
Emphasis Panel; NIAID Peer Review Meeting. mail.nih.gov. Date: September 26–27, 2016.

VerDate Sep<11>2014 21:17 Aug 25, 2016 Jkt 238001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\26AUN1.SGM 26AUN1

Document Created: 2016-08-26 10:40:57
Document Modified: 2016-08-26 10:40:57

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 27, 2016.
FR Citation		81 FR 58950

81 FR 58950 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 166 (August 26, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health